This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.
Subscribe to the Daily Journal for access to Daily Appellate Reports, Verdicts, Judicial Profiles and more...

Investments

Dec. 9, 2003

Saegis Bolsters Drug Research With $30 Million

Venture capitalists have poured $30 million into Saegis Pharmaceuticals Inc., bolstering its efforts to develop new drugs to improve brain function.

By Toni Vranjes
        Venture capitalists have poured $30 million into Saegis Pharmaceuticals Inc., bolstering its efforts to develop new drugs to improve brain function.
        The company, based in Half Moon Bay, will use the new funds to support clinical trials of drugs to treat Alzheimer's disease and schizophrenia. Saegis received legal cou...

To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!

Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)

Already a subscriber?

Sign up for Daily Journal emails